Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 05:02:23 +0200Tue, 21 May 2024 16:25:00 +0200Human medicines European public assessment report (EPAR): Tepmetko, tepotinib, Date of authorisation: 16/02/2022, Revision: 3, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tepmetkoHuman medicines European public assessment report (EPAR): Tepmetko, tepotinib, Date of authorisation: 16/02/2022, Revision: 3, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tepmetkoTue, 21 May 2024 16:25:00 +0200Human medicineTepmetko : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5524-en_1.pdfTepmetko : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5524-en_1.pdfTue, 21 May 2024 10:11:00 +0200Human medicine